102 related articles for article (PubMed ID: 19322876)
1. Effect of a prostaglandin EP4 receptor agonist on early fixation of hydroxyapatite/titanium composite- and titanium-coated rough-surfaced implants in ovariectomized rats.
Hayashi K; Fotovati A; Abu Ali S; Nakamura Y; Inagaki M; Naito M
J Biomed Mater Res A; 2010 Mar; 92(3):1202-9. PubMed ID: 19322876
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin EP4 receptor agonist augments fixation of hydroxyapatite-coated implants in a rat model of osteoporosis.
Hayashi K; Fotovati A; Ali SA; Oda K; Oida H; Naito M
J Bone Joint Surg Br; 2005 Aug; 87(8):1150-6. PubMed ID: 16049256
[TBL] [Abstract][Full Text] [Related]
3. The role of titanium implant surface modification with hydroxyapatite nanoparticles in progressive early bone-implant fixation in vivo.
Lin A; Wang CJ; Kelly J; Gubbi P; Nishimura I
Int J Oral Maxillofac Implants; 2009; 24(5):808-16. PubMed ID: 19865620
[TBL] [Abstract][Full Text] [Related]
4. Osseointegration of titanium alloy and HA-coated implants in healthy and ovariectomized animals: a histomorphometric study.
Vidigal GM; Groisman M; Gregório LH; Soares Gde A
Clin Oral Implants Res; 2009 Nov; 20(11):1272-7. PubMed ID: 19832768
[TBL] [Abstract][Full Text] [Related]
5. In vivo comparison of the osseointegration of vacuum plasma sprayed titanium- and hydroxyapatite-coated implants.
Aebli N; Krebs J; Stich H; Schawalder P; Walton M; Schwenke D; Gruner H; Gasser B; Theis JC
J Biomed Mater Res A; 2003 Aug; 66(2):356-63. PubMed ID: 12889006
[TBL] [Abstract][Full Text] [Related]
6. Effect of a selective agonist for prostaglandin E receptor subtype EP4 (ONO-4819) on the cortical bone response to mechanical loading.
Hagino H; Kuraoka M; Kameyama Y; Okano T; Teshima R
Bone; 2005 Mar; 36(3):444-53. PubMed ID: 15777678
[TBL] [Abstract][Full Text] [Related]
7. Intermittent administration of human parathyroid hormone (1-34) increases new bone formation on the interface of hydroxyapatitecoated titanium rods implanted into ovariectomized rat femora.
Ohkawa Y; Tokunaga K; Endo N
J Orthop Sci; 2008 Nov; 13(6):533-42. PubMed ID: 19089541
[TBL] [Abstract][Full Text] [Related]
8. Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats.
Ito M; Nakayama K; Konaka A; Sakata K; Ikeda K; Maruyama T
Bone; 2006 Sep; 39(3):453-9. PubMed ID: 16581323
[TBL] [Abstract][Full Text] [Related]
9. Effect of zinc ions on improving implant fixation in osteoporotic bone.
Li X; Li Y; Peng S; Ye B; Lin W; Hu J
Connect Tissue Res; 2013; 54(4-5):290-6. PubMed ID: 23971976
[TBL] [Abstract][Full Text] [Related]
10. Tissue ingrowth into titanium and hydroxyapatite-coated implants during stable and unstable mechanical conditions.
Søballe K; Hansen ES; B-Rasmussen H; Jørgensen PH; Bünger C
J Orthop Res; 1992 Mar; 10(2):285-99. PubMed ID: 1311039
[TBL] [Abstract][Full Text] [Related]
11. The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats.
Kurth AH; Eberhardt C; Müller S; Steinacker M; Schwarz M; Bauss F
Bone; 2005 Aug; 37(2):204-10. PubMed ID: 15936997
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tissue reaction and osteointegration of metal implants between hydroxyapatite/Ti alloy coat: an animal experimental study.
Itiravivong P; Promasa A; Laiprasert T; Techapongworachai T; Kuptniratsaikul S; Thanakit V; Heimann RB
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S422-31. PubMed ID: 12930020
[TBL] [Abstract][Full Text] [Related]
13. Histological and mechanical comparison of hydroxyapatite-coated cobalt-chrome and titanium implants in the rabbit femur.
Friedman RJ; Bauer TW; Garg K; Jiang M; An YH; Draughn RA
J Appl Biomater; 1995; 6(4):231-5. PubMed ID: 8589507
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of bone-bonding ability of bioactive titanium by prostaglandin E2 receptor selective agonist.
Onishi E; Fujibayashi S; Takemoto M; Neo M; Maruyama T; Kokubo T; Nakamura T
Biomaterials; 2008 Mar; 29(7):877-83. PubMed ID: 18045684
[TBL] [Abstract][Full Text] [Related]
15. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD
J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 EP4 receptor-selective agonist facilitates sternal healing after harvesting bilateral internal thoracic arteries in diabetic rats.
Marui A; Hirose K; Maruyama T; Arai Y; Huang Y; Doi K; Ikeda T; Komeda M
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):587-93. PubMed ID: 16515909
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyapatite-coated titanium for orthopedic implant applications.
Cook SD; Thomas KA; Kay JF; Jarcho M
Clin Orthop Relat Res; 1988 Jul; (232):225-43. PubMed ID: 2838208
[TBL] [Abstract][Full Text] [Related]
18. Enhanced bone bonding of hydroxyapatite-coated titanium implants by electrical polarization.
Kobayashi T; Itoh S; Nakamura S; Nakamura M; Shinomiya K; Yamashita K
J Biomed Mater Res A; 2007 Jul; 82(1):145-51. PubMed ID: 17269143
[TBL] [Abstract][Full Text] [Related]
19. Comparison of bone-implant interface shear strength of solid hydroxyapatite and hydroxyapatite-coated titanium implants.
Hayashi K; Inadome T; Mashima T; Sugioka Y
J Biomed Mater Res; 1993 May; 27(5):557-63. PubMed ID: 8314808
[TBL] [Abstract][Full Text] [Related]
20. Bond strength, compositional, and structural properties of hydroxyapatite coating on Ti, ZrO2-coated Ti, and TPS-coated Ti substrate.
Yang Y; Ong JL
J Biomed Mater Res A; 2003 Mar; 64(3):509-16. PubMed ID: 12579565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
